DIETHYLPROPION HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for diethylpropion hydrochloride and what is the scope of freedom to operate?
Diethylpropion hydrochloride
is the generic ingredient in five branded drugs marketed by Lannett Co Inc, Sanofi Aventis Us, Nostrum Labs Inc, 3M, Avanthi Inc, Chartwell Rx, Epic Pharma Llc, Sandoz, Teva, Ucb Inc, and Watson Labs, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for diethylpropion hydrochloride. Eleven suppliers are listed for this compound.
Summary for DIETHYLPROPION HYDROCHLORIDE
US Patents: | 0 |
Tradenames: | 5 |
Applicants: | 11 |
NDAs: | 16 |
Drug Master File Entries: | 1 |
Finished Product Suppliers / Packagers: | 11 |
Raw Ingredient (Bulk) Api Vendors: | 39 |
Clinical Trials: | 2 |
Patent Applications: | 6,535 |
What excipients (inactive ingredients) are in DIETHYLPROPION HYDROCHLORIDE? | DIETHYLPROPION HYDROCHLORIDE excipients list |
DailyMed Link: | DIETHYLPROPION HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for DIETHYLPROPION HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
GlaxoSmithKline | |
New River Pharmaceuticals | Phase 1/Phase 2 |
Pharmacology for DIETHYLPROPION HYDROCHLORIDE
Drug Class | Sympathomimetic Amine Anorectic |
Physiological Effect | Appetite Suppression Increased Sympathetic Activity |
Medical Subject Heading (MeSH) Categories for DIETHYLPROPION HYDROCHLORIDE
US Patents and Regulatory Information for DIETHYLPROPION HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | TENUATE | diethylpropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 017669-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Chartwell Rx | DIETHYLPROPION HYDROCHLORIDE | diethylpropion hydrochloride | TABLET;ORAL | 088267-001 | Aug 25, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Nostrum Labs Inc | TENUATE DOSPAN | diethylpropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 012546-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Chartwell Rx | DIETHYLPROPION HYDROCHLORIDE | diethylpropion hydrochloride | TABLET;ORAL | 088268-001 | Aug 25, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.